Gold has struggled to maintain gains above its 200-day moving average, signaling continued downward momentum and approaching critical support levels around $4,095 and $3,940. Despite this short-term weakness, Société Générale remains optimistic about gold's long-term prospects, citing strong central bank demand, geopolitical risks, and expected lower real interest rates as key drivers. The bank forecasts gold prices to rise to $4,750 by late 2026 and $5,250 by mid-2027, maintaining a 10% portfolio allocation to gold and commodities. This outlook reflects gold's role as a hedge amid inflation concerns and currency credibility issues, supported by renewed investment flows and a softer U.S. dollar.
Gold price movements are the subject of this report, with Pluang market data providing context. Of 150 US stocks priced on Pluang, 45 rose and 103 fell today. Notable movers include RBLX at USD 42.84 with a 1-day change of -7.75%, CVNA at USD 60.07 down 7.67% but with 100% buy order activity, and BB at USD 8.74 up 6.52%. This data is as of Sep 29, 2026 01:11 WIB.
Morgan Stanley raised the price target for Reinsurance Group of America (RGA) to $295, implying a 16.7% upside from its current price of $252.85. The company reported a 42% increase in adjusted operating income to $746 million in H1, driven by its lo...
H.C. Wainwright raised Mirum Pharmaceuticals' price target from $140 to $195 following positive developments: the Phase 3 AZURE-1 trial for Brelovitug met its main goal for treating Chronic Hepatitis Delta Virus, and the FDA approved Atebrioz™ for Fi...
Kodiak Sciences reported successful Phase 3 trial results for its retinal disease treatments Zenkuda and tabirafusp-ted, showing vision improvements comparable to Regeneron's Eylea. Zenkuda allowed 54% of patients to maintain a six-month dosing inter...
Citigroup has maintained a Neutral rating on Regeneron Pharmaceuticals due to increasing competition in the ophthalmology sector. Kodiak Sciences reported positive Phase 3 trial results for its eye drugs, challenging Regeneron's key product, Eylea, e...
Bittensor has introduced a proposal for Gamma tokens, a new economic layer allowing its subnets to trade compute and inference services using credits backed by their own TAO emissions. This shifts TAO from being solely a reward token to also serving ...
